Inovio: $17 to $21 short (Overvalued + Small Dip)

Please remember everything I say is on the basis of opinion and not meant to be face value. That being said, Inovio pharmaceuticals is overvalued given its hugely bullish increase, but has one of the biggest growth potentials for 1 to 3 weeks. Again, this is likely a quick sale stock rather then long term. A primary reason for the quick sale would be the fact that Inovio is working on a Coronavirus related vaccine. Given this, you could expect a potentially sudden increase in price, but soon just as sudden or as deep of a decrease. That is why it would be good to invest in the dip (which slightly just passed), but still hold this for a few weeks, then reinvest much later on, when news is about to come related to clinical trials and such. That way you put less risk on a hugely bearish decrease. The post-market is already negative, but I think next few weeks Inovio still has even some growth potential in its continued bull run. It does look like this small biotech company should be on the watchlist for many investors. Though I recommend a swing strategy, this doesn't necessarily condone doing a long hold instead, but it is less risk and has better potential (in my opinion).